Witney, TH;
James, ML;
Shen, B;
Chang, E;
Pohling, C;
Arksey, N;
Hoehne, A;
... Gambhir, SS; + view all
(2015)
PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2.
Science Translational Medicine
, 7
(310)
, Article 310ra169. 10.1126/scitranslmed.aac6117.
Preview |
Text
Witney_aac6117_final edits.pdf Download (1MB) | Preview |
Preview |
Text
Witney_aac6117_SupplementalMaterial_final edits.pdf Download (741kB) | Preview |
Abstract
Cancer cells reprogram their metabolism to meet increased biosynthetic demands, commensurate with elevated rates of replication. Pyruvate kinase M2 (PKM2) catalyzes the final and rate-limiting step in tumor glycolysis, controlling the balance between energy production and the synthesis of metabolic precursors. We report here the synthesis and evaluation of a positron emission tomography (PET) radiotracer, [(11)C]DASA-23, that provides a direct noninvasive measure of PKM2 expression in preclinical models of glioblastoma multiforme (GBM). In vivo, orthotopic U87 and GBM39 patient-derived tumors were clearly delineated from the surrounding normal brain tissue by PET imaging, corresponding to exclusive tumor-associated PKM2 expression. In addition, systemic treatment of mice with the PKM2 activator TEPP-46 resulted in complete abrogation of the PET signal in intracranial GBM39 tumors. Together, these data provide the basis for the clinical evaluation of imaging agents that target this important gatekeeper of tumor glycolysis.
| Type: | Article |
|---|---|
| Title: | PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2 |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1126/scitranslmed.aac6117 |
| Publisher version: | http://dx.doi.org/10.1126/scitranslmed.aac6117 |
| Language: | English |
| Additional information: | Copyright © 2015, American Association for the Advancement of Science. This is the author’s version of the work. It is posted here by permission of the AAAS for personal use, not for redistribution. The definitive version was published in Science Translational Medicine, vol. 7, on 21/10/15, DOI: 10.1126/scitranslmed.aac6117. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Experimental and Translational Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1472072 |
Archive Staff Only
 |
View Item |
